Annual SG&A:
$0.00-$116.81M(-100.00%)Summary
- As of today, BEAM annual SG&A is $0.00, with the most recent change of -$116.81 million (-100.00%) on December 31, 2024.
- During the last 3 years, BEAM annual SG&A has fallen by -$57.22 million (-100.00%).
- BEAM annual SG&A is now -100.00% below its all-time high of $116.81 million, reached on December 31, 2023.
Performance
BEAM SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly SG&A:
$26.86M-$1.08M(-3.87%)Summary
- As of today, BEAM quarterly SG&A is $26.86 million, with the most recent change of -$1.08 million (-3.87%) on June 30, 2025.
- Over the past year, BEAM quarterly SG&A has dropped by -$2.77 million (-9.34%).
- BEAM quarterly SG&A is now -37.91% below its all-time high of $43.26 million, reached on December 31, 2023.
Performance
BEAM Quarterly SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM SG&A:
-$6.50B-$398.58M(-6.54%)Summary
- As of today, BEAM TTM SG&A is -$6.50 billion, with the most recent change of -$398.58 million (-6.54%) on June 30, 2025.
- Over the past year, BEAM TTM SG&A has dropped by -$6.62 billion (-5296.89%).
- BEAM TTM SG&A is now -5109.35% below its all-time high of -$124.72 million.
Performance
BEAM TTM SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Selling, General & Administrative Expenses Formula
SG&A = Total Operating Expenses - Cost of Goods Sold - Research & Development
BEAM Selling, General & Administrative Expenses Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1Y1 Year | -100.0% | -9.3% | -5296.9% |
3Y3 Years | -100.0% | +11.6% | -8553.6% |
5Y5 Years | -100.0% | +287.2% | -10000.0% |
BEAM Selling, General & Administrative Expenses Highs & Lows
PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
---|---|---|---|---|---|---|---|
3Y | 3-Year | -100.0% | at low | -37.9% | +23.1% | -83.8% | at low |
5Y | 5-Year | -100.0% | at low | -37.9% | +258.0% | -545.5% | at low |
All-Time | All-Time | -100.0% | at low | -37.9% | +847.7% | -5109.4% | at low |
BEAM Selling, General & Administrative Expenses History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Jun 2025 | - | $26.86M(-3.9%) | $109.97M(-2.5%) |
Mar 2025 | - | $27.94M(-2.5%) | $112.74M(+1.1%) |
Dec 2024 | $0.00(-100.0%) | $28.66M(+8.1%) | $111.53M(-11.6%) |
Sep 2024 | - | $26.52M(-10.5%) | $126.12M(+0.9%) |
Jun 2024 | - | $29.63M(+10.9%) | $125.02M(+4.1%) |
Mar 2024 | - | $26.72M(-38.2%) | $120.05M(+2.8%) |
Dec 2023 | $116.81M(+33.0%) | $43.26M(+70.2%) | $116.81M(+21.4%) |
Sep 2023 | - | $25.41M(+3.1%) | $96.24M(+3.9%) |
Jun 2023 | - | $24.66M(+5.0%) | $92.64M(+0.6%) |
Mar 2023 | - | $23.49M(+3.6%) | $92.05M(+4.8%) |
Dec 2022 | $87.81M(+53.4%) | $22.68M(+4.0%) | $87.81M(+5.9%) |
Sep 2022 | - | $21.82M(-9.3%) | $82.90M(+7.9%) |
Jun 2022 | - | $24.06M(+25.0%) | $76.86M(+16.1%) |
Mar 2022 | - | $19.25M(+8.3%) | $66.20M(+15.7%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Dec 2021 | $57.22M(+93.3%) | $17.77M(+12.7%) | $57.22M(+19.7%) |
Sep 2021 | - | $15.77M(+17.7%) | $47.80M(+20.9%) |
Jun 2021 | - | $13.40M(+30.5%) | $39.53M(+19.6%) |
Mar 2021 | - | $10.27M(+23.0%) | $33.07M(+11.7%) |
Dec 2020 | $29.61M(+44.0%) | $8.35M(+11.4%) | $29.61M(+8.0%) |
Sep 2020 | - | $7.50M(+8.1%) | $27.41M(+7.9%) |
Jun 2020 | - | $6.94M(+1.8%) | $25.40M(+8.4%) |
Mar 2020 | - | $6.81M(+10.6%) | $23.44M(+14.0%) |
Dec 2019 | $20.55M(+73.2%) | $6.16M(+12.3%) | $20.55M(+13.5%) |
Sep 2019 | - | $5.49M(+10.2%) | $18.10M(+17.2%) |
Jun 2019 | - | $4.98M(+26.7%) | $15.45M(+47.5%) |
Mar 2019 | - | $3.93M(+5.9%) | $10.47M(+60.0%) |
Dec 2018 | $11.87M(+487.2%) | $3.71M(+30.9%) | $6.54M(+130.9%) |
Sep 2018 | - | $2.83M | $2.83M |
Dec 2017 | $2.02M | - | - |
FAQ
- What is Beam Therapeutics Inc. annual SG&A?
- What is the all-time high annual SG&A for Beam Therapeutics Inc.?
- What is Beam Therapeutics Inc. annual SG&A year-on-year change?
- What is Beam Therapeutics Inc. quarterly SG&A?
- What is the all-time high quarterly SG&A for Beam Therapeutics Inc.?
- What is Beam Therapeutics Inc. quarterly SG&A year-on-year change?
- What is Beam Therapeutics Inc. TTM SG&A?
- What is the all-time high TTM SG&A for Beam Therapeutics Inc.?
- What is Beam Therapeutics Inc. TTM SG&A year-on-year change?
What is Beam Therapeutics Inc. annual SG&A?
The current annual SG&A of BEAM is $0.00
What is the all-time high annual SG&A for Beam Therapeutics Inc.?
Beam Therapeutics Inc. all-time high annual SG&A is $116.81M
What is Beam Therapeutics Inc. annual SG&A year-on-year change?
Over the past year, BEAM annual SG&A has changed by -$116.81M (-100.00%)
What is Beam Therapeutics Inc. quarterly SG&A?
The current quarterly SG&A of BEAM is $26.86M
What is the all-time high quarterly SG&A for Beam Therapeutics Inc.?
Beam Therapeutics Inc. all-time high quarterly SG&A is $43.26M
What is Beam Therapeutics Inc. quarterly SG&A year-on-year change?
Over the past year, BEAM quarterly SG&A has changed by -$2.77M (-9.34%)
What is Beam Therapeutics Inc. TTM SG&A?
The current TTM SG&A of BEAM is -$6.50B
What is the all-time high TTM SG&A for Beam Therapeutics Inc.?
Beam Therapeutics Inc. all-time high TTM SG&A is -$124.72M
What is Beam Therapeutics Inc. TTM SG&A year-on-year change?
Over the past year, BEAM TTM SG&A has changed by -$6.62B (-5296.89%)